trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Radiation Injuries D011832 14 associated lipids
Leishmaniasis D007896 19 associated lipids
Enteritis D004751 8 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Osteomalacia D010018 5 associated lipids
Glioblastoma D005909 27 associated lipids
Keloid D007627 12 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Medulloblastoma D008527 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Cat Diseases D002371 12 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Retinoblastoma D012175 12 associated lipids
Genomic Instability D042822 7 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Mastocytoma D034801 3 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Rombouts K et al. Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. 2002 J. Hepatol. pmid:12445420
Nemajerová A et al. Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. 2003 J. Hematother. Stem Cell Res. pmid:12804181
Wolf G et al. Epigenetic marking and repression of porcine endogenous retroviruses. 2013 J. Gen. Virol. pmid:23324470
Park JJ et al. Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts. 2007 J. Gen. Virol. pmid:18024889
Hummel M et al. Transcriptional reactivation of murine cytomegalovirus ie gene expression by 5-aza-2'-deoxycytidine and trichostatin A in latently infected cells despite lack of methylation of the major immediate-early promoter. 2007 J. Gen. Virol. pmid:17374752
Hatama S et al. Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera. 2001 J. Gen. Virol. pmid:11714976
Izawa M et al. Inhibition of histone deacetylase causes reduction of appressorium formation in the rice blast fungus Magnaporthe oryzae. 2009 J. Gen. Appl. Microbiol. pmid:20118613
Cao W et al. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. 2008 J. Exp. Med. pmid:18504304
Cosio BG et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. 2004 J. Exp. Med. pmid:15337792
Durum SK et al. Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility. 1998 J. Exp. Med. pmid:9858510
Yang QC et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. 2006 J. Exp. Clin. Cancer Res. pmid:17310851
Liu Y et al. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac. 2016 J. Exp. Clin. Cancer Res. pmid:27461117
Zhao Y et al. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. 2005 J. Exp. Biol. pmid:15695762
Jiang Y et al. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. 2008 J. Exp. Biol. pmid:18310117
Sponziello M et al. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. 2010 J. Endocrinol. Invest. pmid:19794300
Lee JH et al. Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1. 2005 J. Endocrinol. pmid:16293776
Margueron R et al. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. 2003 J. Endocrinol. pmid:14529564
Gunin AG et al. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. 2005 J. Endocrinol. pmid:15930180
Korkmaz CG et al. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants. 2004 J. Endocrinol. pmid:15350180
Shi YL et al. Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice. 2012 J. Dermatol. Sci. pmid:22999682
Jo SJ et al. Valproic acid promotes human hair growth in in vitro culture model. 2013 J. Dermatol. Sci. pmid:23810771
Vanniasinkam T et al. Trichostatin-A enhances adaptive immune responses to DNA vaccination. 2006 J. Clin. Virol. pmid:16765083
Song YF et al. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma. 2006 J. Clin. Pathol. pmid:16489177
Wong JE et al. Therapeutic strategies in gastric cancer. 2003 J. Clin. Oncol. pmid:14645406
Mishra N et al. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. 2003 J. Clin. Invest. pmid:12588892
Avila AM et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. 2007 J. Clin. Invest. pmid:17318264
Alikhani-Koopaei R et al. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. 2004 J. Clin. Invest. pmid:15489962
He LZ et al. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. 2001 J. Clin. Invest. pmid:11696577
Zhou X et al. Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice. 2011 J. Clin. Immunol. pmid:21305388
Zhu X et al. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells. 2008 J. Clin. Endocrinol. Metab. pmid:18544619
Catalano MG et al. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells. 2012 J. Clin. Endocrinol. Metab. pmid:22563106
Uramoto H et al. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor. 2004 J. Cell. Sci. pmid:15454570
Bouquet F et al. A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia. 2011 J. Cell. Sci. pmid:21576354
Chang J et al. The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons. 2009 J. Cell. Sci. pmid:19509051
Somech R et al. The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. 2005 J. Cell. Sci. pmid:16129885
Watanabe Y and Tanaka M p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate. 2011 J. Cell. Sci. pmid:21771882
Kimata Y et al. Diminishing HDACs by drugs or mutations promotes normal or abnormal sister chromatid separation by affecting APC/C and adherin. 2008 J. Cell. Sci. pmid:18354085
Dyson MH et al. MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2. 2005 J. Cell. Sci. pmid:15870105
Collas P et al. Active transgenes in zebrafish are enriched in acetylated histone H4 and dynamically associate with RNA Pol II and splicing complexes. 1999 J. Cell. Sci. pmid:10198286
Kanski R et al. Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network. 2014 J. Cell. Sci. pmid:25128567
Tóth KF et al. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. 2004 J. Cell. Sci. pmid:15292402
Bártová E et al. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. 2005 J. Cell. Sci. pmid:16254244
Nakano M et al. Epigenetic assembly of centromeric chromatin at ectopic alpha-satellite sites on human chromosomes. 2003 J. Cell. Sci. pmid:12953060
Breuzard G et al. Molecular mechanisms of Tau binding to microtubules and its role in microtubule dynamics in live cells. 2013 J. Cell. Sci. pmid:23659998
Thangavel J et al. Epigenetic modifiers reduce inflammation and modulate macrophage phenotype during endotoxemia-induced acute lung injury. 2015 J. Cell. Sci. pmid:26116574
Zhou Q et al. TGFbeta mediated transition of corneal fibroblasts from a proinflammatory state to a profibrotic state through modulation of histone acetylation. 2010 J. Cell. Physiol. pmid:20232294
Bianco C et al. Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells. 2013 J. Cell. Physiol. pmid:23129342
Fujii K et al. Lactogenic hormone stimulation and epigenetic control of L-amino acid oxidase expression in lactating mammary glands. 2015 J. Cell. Physiol. pmid:25820447
D'Andrea M et al. Protein kinase C theta co-operates with calcineurin in the activation of slow muscle genes in cultured myogenic cells. 2006 J. Cell. Physiol. pmid:16419034
Mayo C et al. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression. 2007 J. Cell. Physiol. pmid:17311291
Du J et al. HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury. 2015 J. Cell. Physiol. pmid:25475100
Kaichi S et al. Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes. 2011 J. Cell. Physiol. pmid:20665673
Nakamura M et al. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor. 2001 J. Cell. Physiol. pmid:11319763
Chen JS and Faller DV Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. 2005 J. Cell. Physiol. pmid:15389542
Lee EL et al. Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells. 2007 J. Cell. Physiol. pmid:17186499
Shi G et al. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells. 2011 J. Cell. Physiol. pmid:21321941
Sustáčková G et al. Acetylation-dependent nuclear arrangement and recruitment of BMI1 protein to UV-damaged chromatin. 2012 J. Cell. Physiol. pmid:21732356
Chaturvedi V et al. Resistance to UV-induced apoptosis in human keratinocytes during accelerated senescence is associated with functional inactivation of p53. 2004 J. Cell. Physiol. pmid:14584049
Choi YS et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. 2010 J. Cell. Mol. Med. pmid:20070436
Susick L et al. Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells. 2008 Sep-Oct J. Cell. Mol. Med. pmid:18053091
Xiao W et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. 2014 J. Cell. Mol. Med. pmid:24456602
Watson JA et al. Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles. 2010 J. Cell. Mol. Med. pmid:19583812
Choi SY et al. Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. 2016 J. Cell. Mol. Med. pmid:27420561
Hakami NY et al. Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis. 2016 J. Cell. Mol. Med. pmid:27297729
Pufahl L et al. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3. 2012 J. Cell. Mol. Med. pmid:21883892
Habold C et al. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. 2008 J. Cell. Mol. Med. pmid:18419600
Haffner I et al. Regulation of arginase-1 expression in macrophages by a protein kinase A type I and histone deacetylase dependent pathway. 2008 J. Cell. Biochem. pmid:17577214
Majumder S et al. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. 2006 J. Cell. Biochem. pmid:16329111
Ekici M et al. Chromatin structure and expression of the AMPA receptor subunit Glur2 in human glioma cells: major regulatory role of REST and Sp1. 2012 J. Cell. Biochem. pmid:21948504
Han DS et al. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways. 2010 J. Cell. Biochem. pmid:20568119
Liu L and Clipstone NA Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway. 2007 J. Cell. Biochem. pmid:16888802
Liu YW et al. Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells. 2010 J. Cell. Biochem. pmid:20506344
McGhee L et al. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. 2003 J. Cell. Biochem. pmid:12874834
Pujuguet P et al. Trichostatin A inhibits beta-casein expression in mammary epithelial cells. 2001 J. Cell. Biochem. pmid:11746508
Wang Y et al. Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells. 2013 J. Cell. Biochem. pmid:23564418
Sato A et al. Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication. 2013 J. Cell. Biochem. pmid:23519646
Son YO et al. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata. 2006 J. Cell. Biochem. pmid:16817225
Peng C et al. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. 2006 J. Cell. Biochem. pmid:16265664
Iacomino G et al. Effects of histone deacetylase inhibitors on p55CDC/Cdc20 expression in HT29 cell line. 2006 J. Cell. Biochem. pmid:16795040
Hobbs CA and Gilmour SK High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. 2000 J. Cell. Biochem. pmid:10760944
Dalla Pozza E et al. Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: An in depth proteomic study. 2018 J. Cell. Biochem. pmid:29095525
Curtin BF et al. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure. 2005 J. Cell. Biochem. pmid:16149071
Fan X et al. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells. 2004 J. Cell. Biochem. pmid:15389882
Nambiar MP et al. Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling. 2002 J. Cell. Biochem. pmid:11967985
Cho HH et al. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. 2005 J. Cell. Biochem. pmid:16088945
Felisbino MB et al. Changes in chromatin structure in NIH 3T3 cells induced by valproic acid and trichostatin A. 2014 J. Cell. Biochem. pmid:24913611
Wisnieski F et al. BMP8B Is a Tumor Suppressor Gene Regulated by Histone Acetylation in Gastric Cancer. 2017 J. Cell. Biochem. pmid:27748538
Orlova DY et al. Arrangement of nuclear structures is not transmitted through mitosis but is identical in sister cells. 2012 J. Cell. Biochem. pmid:22644811
Law AY et al. Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29. 2011 J. Cell. Biochem. pmid:21465530
Pang M et al. Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins. 2011 J. Cell. Biochem. pmid:21465537
Rodrigues MF et al. Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells. 2015 J. Cell. Biochem. pmid:25510910
Zhu S et al. TSA-induced JMJD2B downregulation is associated with cyclin B1-dependent survivin degradation and apoptosis in LNCap cells. 2012 J. Cell. Biochem. pmid:22388778
Xiao H et al. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. 1999 J. Cell. Biochem. pmid:10321829
Kang JH et al. CCAAT box is required for the induction of human thrombospondin-1 gene by trichostatin A. 2008 J. Cell. Biochem. pmid:18275041
De Luca P et al. Retinoblastoma protein tethered to promoter DNA represses TBP-mediated transcription. 1998 J. Cell. Biochem. pmid:9671233
Huynh NC et al. Inhibition of Histone Deacetylases Enhances the Osteogenic Differentiation of Human Periodontal Ligament Cells. 2016 J. Cell. Biochem. pmid:27043246
Roy S et al. Histone deacetylase 5 represses the transcription of cyclin D3. 2008 J. Cell. Biochem. pmid:18404677
Krouwels IM et al. A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain. 2005 J. Cell Biol. pmid:16103223
Contreras AU et al. Deacetylation of p53 induces autophagy by suppressing Bmf expression. 2013 J. Cell Biol. pmid:23629966
Murga M et al. Global chromatin compaction limits the strength of the DNA damage response. 2007 J. Cell Biol. pmid:17893239